Metabolic conditioning of CD8+ effector T cells for adoptive cell therapy
Ramon I. Klein Geltink(University of British Columbia), Franziska Maria Uhl(University of Freiburg), Mario Fabri(University of California, Los Angeles), Petya Apostolova(University of Freiburg), Fabian Hässler(Max Planck Institute of Immunobiology and Epigenetics), Daniel J. Puleston(Bloomberg (United States)), David O’Sullivan(Max Planck Institute of Immunobiology and Epigenetics), Michal A. Stanczak(Bloomberg (United States)), David E. Sanin(Agency for Science, Technology and Research), Erika L. Pearce(Bloomberg (United States)), Agnieszka M. Kabat(Bloomberg (United States)), Nina A. M. Ligthart(Max Planck Institute of Immunobiology and Epigenetics), Joerg M. Buescher(VIB-KU Leuven Center for Microbiology), Katarzyna M. Grzes(Max Planck Institute of Immunobiology and Epigenetics), Robert Zeiser(University of Freiburg), Edward J. Pearce(Bloomberg (United States)), Joy Edwards-Hicks(University of Basel), Jonathan D. Curtis(Trudeau Institute), Annette E. Patterson(Max Planck Institute of Immunobiology and Epigenetics)
Cited by 143
Related Papers
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
|Blood|2010|1.2k
TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation
|Nature Immunology|2014|1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
A roadmap for interpreting 13C metabolite labeling patterns from cells
|Current Opinion in Biotechnology|2015|652